Aprogen Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.

Top 17 shareholders own 54.37% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
29.4%	G-Baise Inc.	71,783,159	₩111.6b	0%	no data
10.9%	Nexkonics Inc.	26,470,423	₩41.2b	0%	no data
5.46%	Jae-Seob Kim	13,328,002	₩20.7b	0%	no data
5.12%	Nichi-Iko Pharmaceutical Co., Ltd.	12,495,499	₩19.4b	0%	no data
2.76%	Miryeong Park	6,739,068	₩10.5b	0%	no data
0.46%	Jung-Chul Kim	1,123,427	₩1.7b	0%	no data
0.14%	Dimensional Fund Advisors LP	339,913	₩528.6m	0%	no data
0.081%	Seon-ju Kang	198,187	₩308.2m	0%	no data
0.034%	State Street Global Advisors, Inc.	83,324	₩129.6m	-11.6%	no data
0.025%	Hanwha Asset Management Co. Ltd.	61,548	₩95.7m	0%	no data
0.013%	KB Asset Management Co., Ltd.	31,835	₩49.5m	11.9%	no data
0.0083%	Mirae Asset Global Investments Co., Ltd.	20,140	₩31.3m	-21.1%	no data
0.008%	American Century Investment Management Inc	19,622	₩30.5m	-64.1%	no data
0.0054%	Samsung Asset Management Company, Ltd.	13,159	₩20.5m	-3.72%	no data
0.00031%	Invesco Capital Management LLC	757	₩1.2m	0%	no data
0.0003%	Kyobo AXA Investment Managers Co., Ltd.	736	₩1.1m	0%	no data
0.00008%	Korea Investment Management Co., Ltd.	195	₩303.6k	-79.7%	no data